Success Stories: Despite Waiting for Long, A South Korean Researcher Secured I-140 NIW Approval in the Field of Pharmaceutical Science (27 Citations + Outstanding record)
Client’s Testimonial:
“Overall, I am very happy with the experience that I have with you. When I had questions, you were able to address them in a timely fashion and guide me throughout the whole process. I greatly appreciate all of your help and effort to put into my I-140 petition.”
On April 16th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Pharmaceutical Science (Approval Notice).
General Field: Pharmaceutical Science
Position at the Time of Case Filing: Researcher
Country of Origin: South Korea
Approval Notice Date: April 16th, 2021
Processing Time: 15 months
Case Summary:
With a doctorate of pharmacy (PharmD) degree, a South-Korea based researcher intending to advance in the field of pharmaceutical science hired North America Immigration Law Group to file an EB-2 NIW (National Interest Waiver) petition on her behalf. After she contacted us, our associated team started scrutinizing her credentials. Following a thorough assessment, we accumulated an array of important details pertaining to her educational and professional successes. Thus, we listed the subsequent points that paved the way for her national interest waiver progress.
- Research Summary- Our client’s work focused on performing data analysis, interpretation, and modeling and simulation research in the specific area of clinical pharmacology and pharmacokinetic/pharmacodynamic and how it is of great importance. We concluded that her research is crucial because it lays the foundation of drug discovery and development. Therefore, her intended work represents great strides in pharmaceutical science, and her ongoing contributions are essential to ensuring U.S. superiority in this area.
- Publication & Citation Count- We also detailed her publication record of 4 peer-reviewed journal articles (1 of them first-authored), which had accumulated 27 citations from the other foremost researchers in the field. All of these are well-read and – cited in the field of pharmaceutical sciences, and the publication of her work has rendered outstanding exposure to her findings, which speaks volumes of her status as a leading expert in the pharmaceutical sciences field.
- Peer Review Experience- Not only did she have a noble record of achievement in publications and citations but she had already conducted 2 peer reviews for elite journals as a peer reviewer in the field. With her nuanced knowledge of the many facets of the pharmaceutical science field, she is certainly an invaluable asset to the U.S.
- Testimonials- To encourage our client’s EB-2 petition further, we included five of her obtained recommendation letters from other well-noted researchers in the field. Below is the statement cited from one of the letters:
Overall, we are delighted to help our client in achieving the NIW approval despite a long wait. Special thanks to our team for constantly supporting her, and we would like to thank her as well for trusting and coordinating with us throughout the process. We wish her the best as she continues to progress in her chosen field.